Cancers of the Colon, Rectum, and Anus
CANCERS OF THE COLON, RECTUM, AND ANUS 480 Oral Abstract Session, Sat, 10:45 AM-12:15 PM and Poster Session (Board #C1), Sat, 7:00 AM-7:55 AM and 12:15 PM-1:45 PM A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results. Carl Christoph Schimanski, Stefan Kasper, Susanna Hegewisch-Becker, Jan Schroeder, Friedrich Overkamp, Frank Kullmann, Wolf Otto Bechstein, Matthias V¨ohringer, Robert Oellinger, Florian Lordick, Volker Heinemann, Michael Geissler, Armin Schulz-Abelius, Bernhard Linz, Helga Bernhard, Michael R. Schoen, Richard Greil, Victoria Smith-Machnow, Irene Schmidtmann, Markus Hermann Moehler; Klinikum Darmstadt GmbH and Universit¨atsmedizin der Johannes Gutenberg-Universit¨at Mainz, Darmstadt and Mainz, Germany; Universit¨atsklinikum Essen (A¨oR), Essen, Germany; H¨amatologisch-Onkologische Praxis Eppendorf (HOPE), Hamburg, Germany; Praxis f¨ur H¨amatologie und Onkologie, M¨ullheim a.d.R., Germany; Oncologianova GmbH Recklinghausen, Recklinghausen, Germany; Kliniken Nordoberpfalz AG, Weiden I.d.O., Germany; Universit¨atsklinikum Frankfurt, Frankfurt, Germany; Robert-Bosch-Krankenhaus, Stuttgart, Germany; Charit´e Campus Virchow-Klinikum, Berlin, Germany; Universit¨atsklinikum Leipzig, Leipzig, Germany; Klinikum der Universit¨at M¨unchen Campus Großhadern, M¨unchen, Germany; Klinikum Esslingen GmbH, Esslingen, Germany; Klinikum Altenburger Land GmbH, Altenburg, Germany; Gemeinschaftspraxis
[Show full text]